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Abstract
Chronic Obstructive Pulmonary Disease (COPD) is a long-term progressive inflammatory lung disease causing chronic 
breathlessness and many hospital admissions. It affects up to 1.2 million people in the UK. To help people with COPD self-
manage their condition we developed, in partnership with healthcare users, a digital mobile phone app called COPD.Pal®. 
We report the first user feedback of COPD.Pal®, applying the Technology Acceptance Model (TAM) theoretical framework.
11 participants engaged with a click dummy version of COPD.Pal® before being asked questions relating to their experiences. 
A deductive, semantic, reflexive thematic analysis was conducted to analyse their individual and collective experiences. The 
study was registered at Clinical Trials.gov (NCT04142957).
Two overarching themes resulted: Ease of Use and Perceived Usefulness. Within the former, participants discussed how 
they wanted flexibility and choice in how they engaged with the app; including how often they used it. Additionally, they 
discussed how the app layout should make it straightforward to use, whilst unanimously agreeing that COPD.Pal® provided 
this. Within Perceived Usefulness, participants discussed how they wanted the information they entered into the app to be 
useful, in addition to the app providing resources regarding COPD. Lastly, there was disagreement regarding preferences 
for further app development.
We found that COPD.Pal® was usable and acceptable by people with COPD and TAM provided a useful theoretical frame-
work for both structuring discussions with users and analysing their comments.
Keywords Chronic obstructive pulmonary disease · Technology acceptance model · Self-management · User-centred 
design · Reflective thematic analysis
1 Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a global 
problem, with 210 million sufferers and 3 million deaths 
annually [1]. It is predicted to become the third most com-
mon cause of death worldwide by 2030 [2]. There are 1.2 
million people with known COPD in the UK, but this is 
likely to be an underestimate [3]. People with COPD have 
daily symptoms, a poorer health status, reduced exercise 
capacity, and impairment in lung function [4]. Recurrent 
exacerbations can lead to hospital admissions and deteriora-
tion in quality of life and increased mortality [4].
Despite people with the condition being extensive users 
of the National Health Service (NHS) [5, 6], approximately 
only 1% of their time is spent with healthcare professionals 
[7]. The rest of the time, people with COPD are increasingly 
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encouraged to self-manage their condition; here behaviours 
including regular exercise, taking prescribed medication, being 
aware of symptoms, and attending healthcare appointments are 
encouraged [8]. Supporting self-management behaviours has 
been highlighted as crucial for the care of people with COPD 
[9]. Despite the positive relationship between more self-man-
agement and better health outcomes [10], these behaviours are 
seldom conducted daily [11] and adherence to medication is 
historically low [12, 13].
One person with COPD created a simple diary, to enable 
greater awareness of the change in his symptoms and identify 
when he was likely to have an exacerbation and thus take pre-
ventative action. Bond Digital Health Ltd. (BDH; Cardiff, UK; 
https ://bondh ealth .co.uk/) first transformed this paper tool into 
an electronic diary, then a smart phone app. ‘COPD.Pal®’ aims 
to allow people with COPD to track and manage their condition. 
The interface replicates a simple text-based system (see Fig. 1), 
so anyone who can use SMS messaging can use it. COPD.Pal® 
can ask questions regarding symptoms (e.g. COPD Assessment 
Test [14]), wellness (e.g. quality of life, such as EQ-5D [15]), 
and medication usage; including increasing or decreasing use of 
symptom reliever inhalers. The app can also send reminders to 
follow individual self-management plans.
Despite healthcare mobile phone apps becoming increas-
ingly prevalent, few of these devices have been developed 
through co-production with end-users or been properly evalu-
ated in a clinical setting for people with COPD [16].
Others have attested to the value of qualitative methodology 
within medicine to help further understanding and knowledge 
[17]. Researchers and healthcare designers should apply theo-
retical constructs to facilitate intervention development [18] 
so we applied the Technology Acceptance Model (TAM; see 
Fig. 2) [19]. TAM posits that the greater the perceived use-
fulness and ease of use is, the greater behavioural intention 
will be and thus actual use of the technology. Additionally, 
perceived ease of use influences perceived usefulness, in that 
as the former increases, so too does the latter. These relation-
ships within the theory are demonstrated by the arrows shown 
in Fig. 2. This theory has been used previously to understand 
acceptance of other healthcare technologies [20, 21].
This first phase study empirically explores the early 
development of COPD.Pal® using qualitative methodology 
to answer the question: ‘how do people with COPD expe-
rience the usability and acceptability of the COPD.Pal® 
app?’.
2  Methods
NHS Research Ethics Committee (19/LO/1649) and R&D 
approvals were received, and the study was pre-registered 
online (ClinicalTrials.gov - NCT04142957).
2.1  Participants
People with COPD were identified by the clinical research 
team from the research COPD database (in Prince Philip 
Hospital, Wales), hospital clinics, pulmonary rehabilita-
tion lists, Breathe Easy groups, and Respiratory Innova-
tion Wales’ (https ://riwal es.com/) Expert Patient Network.
85 people meeting the inclusion and exclusion criteria 
(see Table 1) were invited to take part in the study. The 
team arranged a mutually beneficial date and time with 
15 people, with 11 showing up on the single day. Table 2 
describes the 11 who took part with the focus group.
Fig. 1  COPD.Pal’s text-based system
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2.2  Procedure
Potential participants were posted an invitation letter and 
Participant Information Sheet (PIS) and asked to return a 
pre-paid reply or telephone the researchers.
The focus group was held in a location with free 
parking and easier access than a hospital as this was 
felt important by our patient and public involvement 
group and travel expenses were reimbursed. A written 
informed consent form was obtained upon arrival from 
each participant.
Participants engaged with the first version of the app 
using a click dummy (a partly interactive prototype of 
the application) loaded on to smart phones which were 
provided by BDH. The participants were given as long 
as necessary to use the application and were supported 
by three of the authors if they had any queries.
A semi-structured focus group was led by an experienced 
qualitative researcher with an observer and audio recorded. 
Questions were asked relating to the usability and accept-
ability of COPD.Pal® (see the Interview Schedule, Sup-
plementary File 1). The focus group lasted approximately 
60 min. Only one focus group was conducted due to time 
and funding restrictions.
3  Analysis
Each interviewee was given a number and information that 
revealed their identity was removed to ensure anonymity. A 
verbatim account of the focus group was produced.
A reflexive thematic analysis [22, 23] was applied to allow 
the analysis of multiple components relating to the research 
area [24]. This analysis method was also most appropriate 
due to the sparsity of current research within technology, self-
management apps for people with COPD [25]. Transcripts 
were coded using an inductive (data-driven) procedure, but 
themes were interpreted and contextualised according to con-
cepts within the TAM (see Fig. 2). Thus, whilst the initial cod-
ing remained data-driven, focusing on the content within the 
transcript, the analysis adopted a more theoretically-driven 
approach, exploring the level to which codes fit with the the-
ory, similar to others within a health context [26]. Semantic 
themes were focused upon during the analysis in an aim to 
identify surface-level views [27] and opinions regarding the 
usability and acceptability of a click-dummy version of COPD.
Pal®. This is opposed to latent themes which would aim to 
understand underlying ideas, patterns, and assumptions [27].
4  Results
We summarise how participants described their experiences 
of COPD.Pal®, using the TAM (see Fig. 2) overarching the-
oretical framework, particularly within the concepts of Ease 
of use and Perceived usefulness.
4.1  Ease of use
Within this overarching theme the authors developed two 
sub-themes; Flexibility and choice and App layout.
Fig. 2  The Technology Acceptance Model (Davies, et al., 1989)
Table 1  Inclusion and exclusion criteria.  FEV1 = Forced expiratory volume during the first second, FVC = Forced vital capacity
Inclusion Criteria Exclusion Criteria
Willing and able to provide written informed consent Unwilling or unable to provide written informed consent
Clinical diagnosis of COPD as defined by GOLD (4):
40 years or older
• At least 10 pack-years smoking history
• Spirometry FEV1/FVC ratio less than 70%
• FEV1 less than 80% predicted (4)
Cognitive, visual, or hearing impairment which would affect com-
munication in a group-setting or ability to see and use a smart 
phone
Owns or has access to a smart phone
Table 2  Participant characteristics. Unless otherwise stated, all fig-
ures given show the mean value with standard deviation in parenthe-
ses.  FEV1 = Forced expiratory volume during the first second
Characteristic N = 11
Age (years) 66.5 (5.7)
Gender (n) Male = 8, Female = 3
FEV1% predicted 52.1 (19.8)
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Participants discussed how they wanted greater flex-
ibility and choice with how they engaged with the COPD.
Pal® app. This topic was discussed at the beginning of 
the focus group in addition to re-emerging organically 
throughout the discussion. Whilst discussing how often 
they wished to engage with the app, there was some dis-
agreement within the group; however, one participant 
suggested being given the choice which quickly gained 
positive remarks from all.
“Well yes definitely I think the more choice and 
information you have the better, so it’s down to the 
individual to choose what they do and do not do”. 
Participant 6.
This choice was also extended to what ‘add-ons’ (i.e. 
extra measures and functions) should be added to the app 
or included in future additions. Lastly within this sub-
theme, participants discussed how they did not want to 
lose their data if they broke their phone or bought a new 
one. Therefore, it was suggested that the information 
should be stored online so that it could be accessed by 
multiple devices simultaneously if necessary.
Participants also discussed how the app layout should 
be easy to engage with and suggested a dashboard or 
calendar could be beneficial to interpret data over time. 
The participants felt this type of layout would help both 
people with COPD and healthcare professionals.
Throughout the focus group, participants repeatedly 
stated that they would be unlikely to use the app if the 
data was not being used by someone. Some of partici-
pants wanted to engage with the app solely to help their 
healthcare professional make health-related decisions 
during appointments. Therefore, it was believed that if 
the information was presented in a too complicated fash-
ion, the healthcare provider would then disengage which 
would result in the person with COPD also giving-up.
“Is the doctor or the GP going to be switched on to 
get that data? Or will he be trained up or whatever? 
Because some of the researchers would likely be able 
to understand it, but the local GPs probably want to 
go and play golf at 3 o’clock!” Participant 2.
Participants unanimously agreed that the current ver-
sion of COPD.Pal® was extremely easy to use because of 
the layout and display of the app.
“It’s crisp, easy to read, good fonts, I suffer with 
severe dyslexia and I struggle to read, but that was 
easy to read” Participant 4.
This was seen as a large benefit as the group discussed 
that even those with poorer computer skills would still be 
able to engage with the app.
4.2  Perceived usefulness
Within this overarching theme the authors developed three 
sub-themes from the transcript; Used by anyone, App devel-
opment, and Greater information.
Participants emphasised several times that the infor-
mation entered into the app had to be used by someone. 
Although there was disagreement regarding for whom 
COPD.Pal® could be most beneficial, participants agreed 
that providing the information was being used by someone 
(healthcare professional or themselves) they would continue 
to engage with it.
“I want to know that when I go and give [GP] the data 
he would use it rather than look at it and shrug” Par-
ticipant 5.
“Well any information you enter [into COPD.Pal®] 
will be useful to someone, it’s useful to yourself. It’s 
not a waste of time to do it” Participant 6.
Participants did believe there were situations where 
COPD.Pal® could benefit both healthcare professionals and 
people with COPD.
“When you go and see your specialist once or twice a 
year, you sit down at the reception and you fill in that 
form every time…but now with the app you don’t have 
to do that and they will have access to the data…it will 
alleviate a lot of form filling” Participant 6.
This could reduce the time taken during clinic visits 
as healthcare users would not have to complete the ques-
tionnaire during the visit (as all the necessary information 
would already be accessible on the app) but be prompted 
by information already available. Several participants also 
highlighted that the information would be more accurate, as 
they would not be relying on their memory.
There was some disagreement within the sub-theme of 
app development. Several participants wanted lots of add-
ons and further versions of the app to be created that would 
increase the perceived usefulness of the device. However, 
other participants maintained too many additional meas-
ures and abilities could make COPD.Pal® harder to use and 
decrease the likelihood of engagement.
“I think [add ons] could be very confusing and poten-
tially make us hypochondriacs…well the more infor-
mation a layman has, the more complicated and imagi-
nary it becomes” Participant 8.
Lastly, there was discussion amongst participants regard-
ing how they wished the app only to focus on their COPD 
and not be expanded to cover other conditions or less rel-
evant causes of their condition.
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The final sub-theme of greater knowledge concerned how 
participants wanted more information regarding the data 
they entered into COPD.Pal®. Participants largely agreed 
that such information could be included rather easily, either 
by having small pop-up information, or through links to a 
COPD.Pal® website explaining various scores.
“Well maybe if you’re not sure about whatever you 
could have a link to [a COPD.Pal®] website to explain 
in easy language what [questionnaire scores] mean. So 
you see ‘20′, ‘well what the hell is that?’, so you click 
the link and you go to the website and then it tells you 
what that means” Participant 6.
5  Discussion
This research study examined how people with COPD expe-
rienced the usability and acceptability of COPD.Pal®, using 
the Technology Acceptance Model as a framework to guide 
the thematic analysis. We found that, in general, participants 
did discuss COPD.Pal® in terms of the app’s ease of use 
and perceived usefulness, and large sections of discourse 
were devoted to the interlinked relationship between these 
two concepts. Although TAM only states that ease of use 
influences perceived usefulness (as opposed to this relation-
ship being reversed; see Fig. 2), several participants within 
this focus group believed that increasing the functionality of 
the app (i.e. increasing perceived usefulness), could nega-
tively impact its usability. Thus, there does appear to be a 
balance between these two concepts, as increasing either 
could increase engagement with COPD.Pal®, but too much 
of one could be at the expense of the other component. 
Future research could investigate whether the relationship 
between TAM’s ease of use and perceived usefulness should 
be reconceptualised.
One element that was repeatedly emphasised throughout 
the focus group was the need for COPD.Pal® to be flex-
ible and provide choice to the individual in how and how 
often they engaged. At several points there was disagreement 
between participants and the ability to choose was often 
considered the solution for making the app accessible for 
the largest number of people. The importance of providing 
choice to people with COPD has been identified previously 
by the authors (unpublished work) and has links with self-
determination theory’s ‘autonomy’ [28]. Within this focus 
group, participants emphasised how COPD effects every-
one differently, and the ability to autonomously engage with 
COPD.Pal® in-line with their needs and wishes was believed 
to be a large benefit. However, this element should not be 
mistaken with a desire for the app not to display reminders, 
as this was felt beneficial to ensure they remembered to enter 
data or even take medication.
Although it is hoped that people with COPD should 
largely be responsible for their own care through self-man-
agement [7, 9], several participants were predominately 
motivated to engage with COPD.Pal® to aid healthcare 
professionals make medical decisions for them. However, 
this was one element in which there was disagreement, with 
several participants wanting to use the data themselves. 
Although this study did not explore possible causes for the 
disagreements, one potential explanation could be how expe-
rienced the participant is with self-management techniques. 
It is plausible that less experienced individuals engage with 
the app to help others make decisions on their behalf, but 
more experienced individuals who have had the disease for 
many years or already undergone Pulmonary Rehabilitation 
or Expert Patient Programmes would be more comfortable 
using the data themselves. It is important to note, however, 
that one participant who identified themselves as being unin-
volved with their own care, believed that entering in their 
data longitudinally could help them identify what exacer-
bated their condition and would increase their self-manage-
ment and COPD knowledge. This belief quickly obtained 
agreement from others. This could be an important finding 
because it suggests that although the participants may be 
motivated to self-manage their condition, they do not pos-
sess the skills to actively engage with the necessary tech-
niques. Additionally, this also represents an important aspect 
of COPD.Pal®, as it indicates that the original aim which 
prompted its development (i.e. empowering the individual), 
could indeed be met through the current or future versions.
Throughout the focus group, participants were extremely 
positive regarding COPD.Pal® and how it could be used to 
enable them or their healthcare professionals to make more 
informed decisions regarding their condition. As a result 
of the high acceptability of the current iteration of the app, 
participants indicated that they would be highly likely to 
continue using COPD.Pal® longitudinally (if given the 
opportunity) where this could see benefits for both them-
selves and healthcare providers.
Regarding the strengths and limitations of this study, 
one major strength is the involvement of people with the 
condition at an extremely early stage of app development. 
Although co-production has been promoted for its signifi-
cant benefits [29] and the proclivity of medical devices 
being released to the public, there appears to be a spar-
sity of surrounding evidence regarding these technolo-
gies. This is not only detrimental for the individual, as 
they may be engaging with unproven or untested techno-
logical devices, but also the developers of these devices 
because it is likely that without addressing underlying 
needs, engagement may be short-lived. One weakness of 
this study is that we only conducted one focus group with 
the target population. Although we would have liked to 
have conducted more groups with a variety of stakeholders 
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(e.g. healthcare providers, more people with COPD) with 
different characteristics (e.g. differing levels of technol-
ogy experience), timing and funding pressures made this 
impossible. However, to overcome this limitation we 
recruited a relatively large sample from both primary and 
secondary care; thus, increasing the breadth of views we 
captured regarding COPD.Pal®. Additionally, neither the 
clinical team nor app developers were present during the 
focus group, which can put the participants at ease. By 
positioning themselves as impartial and separate to COPD.
Pal®, the researchers conducting the focus group were 
able to elicit widespread views – both positive and nega-
tive – regarding the app and this increased the validity of 
our research design.
In conclusion, this study shows that a self-management 
app is both usable and acceptable to people with COPD 
and that TAM is a useful model to conceptualise how 
people discussed COPD.Pal®. Developers of technology 
healthcare interventions should be cognisant of the con-
cepts of perceived usefulness and ease of use to increase 
the likelihood of engagement from the healthcare users. 
Failure to acknowledge TAM, or another readily accessi-
ble framework, could result in a lack of sustained engage-
ment and the wasting of resources. This study provides 
a novel contribution to a field which rarely conducts or 
publishes rigorous early research concerning healthcare 
apps and highlights how significant benefits and data can 
be obtained for system developers through low intensity 
methodology. Future research regarding COPD.Pal® will 
utilise quantitative clinical trial methodology to further 
evaluate and develop the app and ensure that the system 
represents an effective and usable tool for people with 
COPD.
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